Form 4: VolitionRx Executive's Tax Withholding on RSU Vesting

Nicholas Plummer, GC of Volition Diagnostics, had 8,146 shares withheld by VolitionRx to cover tax obligations from restricted stock unit vesting.

Summary

• Nicholas Plummer, General Counsel of Volition Diagnostics, a subsidiary of VolitionRx Ltd., reported a transaction on October 4, 2025.
• The transaction involved the disposition of 8,146 shares of VolitionRx common stock.
• This disposition was a 'F' type transaction, indicating shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations.
• The tax obligations arose from the settlement of 17,333 restricted stock units (RSUs) held by Mr. Plummer.
• The shares were valued at $0.648 per share for the purpose of tax withholding.
• No shares were sold by Mr. Plummer or VolitionRx in this transaction.
• Following this transaction, Mr. Plummer beneficially owns 199,731 shares of VolitionRx common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction (tax withholding on RSU vesting) that is neutral in its implications for the company's operational performance or financial health.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation (restricted stock unit vesting and associated tax withholding). It does not provide information relevant to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine compensation-related transaction and not a sale of shares by the insider.
• Employees: Reflects standard executive compensation practices, which may be viewed positively as a retention mechanism.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding event related to executive compensation and does not provide new information that would alter the fundamental investment thesis for VolitionRx. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on prior analysis.

Keywords

VNRX, VolitionRx, Form 4, Insider Transaction, RSU Vesting, Tax Withholding, Nicholas Plummer, Corporate Governance